| Autor: |
Brasic, James Robert, Barnett, Jacqueline Y., Sheitman, Brian B., Lafargue, R. Todd, Kowalik, S., Kaplan, Diana, Tsaltas, Margaret Owen, Ahmad, Raheela, Nadrich, Robert H., de Fatima Mendonça, Maria |
| Zdroj: |
CNS Spectrums; December 1998, Vol. 3 Issue: 10 p39-46, 8p |
| Abstrakt: |
AbstractIn an open nonblind clinical trial, clomipramine was administered to five previously medicated prepubertal boys with autistic disorder and severe mental retardation unmanageable due to behavior and motor problems. Although all five boys initially displayed marked behavioral symptom reduction, they developed behavioral newotoxicity necessitating discontinuation of clomipramine for all five and immediate hospitalization for three. Serious adverse effects included increased seizure frequency and symptoms of a serotonin syndrome. Our findings indicate that clomipramine enhances adaptive behavior and produces serious adverse effects in severely retarded autistic children whose symptoms were complicated by dyskinesias. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
